Different mRNA and Protein Expression of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitor of Metalloproteinases 1 in Benign and Malignant Prostate Tissue

By Lichtinghagen R.   Musholt P.B.   Lein M.   Romer A.   Rudolph B.   Kristiansen G.   Hauptmann S.   Schnorr D.   Loening S.A.   Jung K.  

European Urology, Vol. 42, Iss. 4, 2002-10 ,pp. : 398-406

Elsevier

Access to resources Recommend Favorite

A radiofrequency method of thermal tissue ablation for benign prostatic hyperplasia

By Bhanot S.M.   Grigor K.M.   Hargreave T.B.   Chisholm G.D.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 427-434

Elsevier

Access to resources Recommend Favorite

Differential Heparanase-1 Expression in Malignant and Benign Pheochromocytomas

By Quiros R.M.   Kim A.W.   Maxhimer J.   Gattuso P.   Xu X.   Prinz R.A.  

Journal of Surgical Research, Vol. 108, Iss. 1, 2002-11 ,pp. : 44-50

Academic Press

Access to resources Recommend Favorite

Increased Bladder Apoptosis with α-1 Adrenoceptor Antagonists in Benign Prostatic Hyperplasia

By Erdoğru T.   Gülkesen K. H.   Kukul E.   Yalçinkaya M.   Karpuzoğlu G.   Baykara M.  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 3, 2002-06 ,pp. : 188-193

Informa Healthcare

Access to resources Recommend Favorite

Distribution of Inflammation, Pre-Malignant Lesions, Incidental Carcinoma in Histologically Confirmed Benign Prostatic Hyperplasia: A Retrospective Analysis

By Di Silverio F.   Gentile V.   De Matteis A.   Mariotti G.   Giuseppe V.   Antonio Luigi P.   Sciarra A.  

European Urology, Vol. 43, Iss. 2, 2003-02 ,pp. : 164-175

Elsevier

Access to resources Recommend Favorite